+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Orthobiologics Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5176044
  • Report
  • August 2020
  • Region: Global
  • 115 Pages
  • Mordor Intelligence


  • Arthrex Inc.
  • Bone Support
  • Globus Medical Inc.
  • Integra Lifesciences
  • Medtronic PLC
  • NuVasive Inc.
The major factors driving the growth of the orthobiologics market are increased incidences of sports injury, road accidents, and osteoarthritis, and increasing adoption of minimally invasive surgeries.
  • The global increase in the number of geriatrics and obese people is likely to lead to consequences, like greater incidences of osteoarthritis. Consequently, the geriatric population and population with obesity are at higher risk of musculoskeletal disorders.
  • As per the World Health Organization (WHO), more developed countries have the oldest population profiles; however, the elder populations are more in the emerging markets. With that, the elder population in the emerging market by 2050 is expected to be more than 250%, compared to a 71% increase in the developed countries.​ Thus, the rise in the geriatric and obese populations is acting as a major driver for the growth of the orthobiologics market.

Key Market Trends

The Osteoarthritis and Degenerative Arthritis Segment is Expected to Experience the Fastest Growth in the Market

Osteoarthritis (OA) is a weakening disease that affects 20% of the world’s population, according to the United Nations. According to the Arthritis Foundation in 2017, an estimated 30.8 million adults are suffering from osteoarthritis. It is the most common cause of disability in adults.

Due to the increasing prevalence of OA, there is an urgent need for a better understanding of the disease pathophysiology, improved early detection, strategies for disease prevention, and early management. Orthobiologics can be one such option for the treatment of OA. According to the American Academy of Orthopaedic Surgeons (AAOS), orthobiologics are biological substances found naturally in the body that help to heal injuries. These treatments include platelet-rich plasma (PRP), prolotherapy, ozone therapy, autologous conditioned serum (ACS), and many others. With the increasing prevalence of OA, as well as the development of innovative products, the market growth is expected to be augmented.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America is expected to dominate the overall market throughout the forecast period. This is due to the increasing incidences of spinal disorders, rising geriatric and obese populations, growing preference for minimally invasive procedures, and increasing physician and patient awareness about newly introduced treatment procedures and technologies. In the North American region, the United States holds the largest market share.

Competitive Landscape

The orthobiologics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of diseases, few other smaller players are expected to enter the market in the coming years. Some of the major players of the market are Sanofi, Stryker, Zimmer Biomet, Seaspine Holdings Corporation, and Medtronic, among others.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Arthrex Inc.
  • Bone Support
  • Globus Medical Inc.
  • Integra Lifesciences
  • Medtronic PLC
  • NuVasive Inc.

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Sports Injuries and Road Accidents
4.2.2 Increasing Incidence of Osteoarthritis
4.2.3 Increasing Geriatric and Obese Population
4.2.4 Increasing Patient Preference for Minimally Invasive Procedures
4.3 Market Restraints
4.3.1 High Costs Associated with Orthobiologic-based Treatments
4.3.2 Preference for Alternative Treatment Options
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Products
5.1.1 Viscosupplementation Products
5.1.2 Demineralized Bone Matrices
5.1.3 Synthetic Orthobiologics
5.1.4 Bone Morphogenic Protein
5.1.5 Allografts
5.1.6 Plasma-rich Protein
5.1.7 Bone Marrow Aspirate Concentrate
5.2 By Application
5.2.1 Osteoarthritis and Degenerative Arthritis
5.2.2 Spinal Fusion
5.2.3 Soft-tissue Injuries
5.2.4 Fracture Recovery
5.2.5 Maxillofacial and Dental Applications
5.3 By End User
5.3.1 Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
5.3.2 Research and Academic Institutes
5.3.3 Dental Clinics and Facilities
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Arthrex Inc.
6.1.2 Sanofi
6.1.3 DePuy Synthes (A Subsidiary of Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Terumo Corporation
6.1.6 Stryker Corporation
6.1.7 Zimmer Biomet
6.1.8 Medtronic PLC
6.1.9 NuVasive Inc.
6.1.10 Integra Lifesciences
6.1.11 Bone Support
6.1.12 Seaspine Holdings Corporation
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Arthrex Inc.
  • Sanofi
  • DePuy Synthes (A Subsidiary of Johnson & Johnson)
  • Globus Medical Inc.
  • Terumo Corporation
  • Stryker Corporation
  • Zimmer Biomet
  • Medtronic PLC
  • NuVasive Inc.
  • Integra Lifesciences
  • Bone Support
  • Seaspine Holdings Corporation
Note: Product cover images may vary from those shown